Adia Nutrition (ADIA) Accumulated Expenses (2024 - 2026)
Adia Nutrition's (ADIA) quarterly Accumulated Expenses came in at $48895.0 in Q1 2026, up 28.96% quarter-over-quarter from $37915.0 in Q4 2025.
Analysis
Adia Nutrition (ADIA) Accumulated Expenses (2024 - 2026) Analysis & Trends
Adia Nutrition (ADIA) has reported Accumulated Expenses for 3 consecutive years, with $48895.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Accumulated Expenses changed N/A year-over-year to $48895.0 in Q1 2026; TTM through Mar 2026 was $48895.0, a N/A change from a year earlier, with the FY2025 full-year figure at $37915.0, up 500.11% from the prior year.
- Accumulated Expenses was $48895.0 for Q1 2026 at Adia Nutrition, up from $37915.0 in the prior quarter.
- Over five years, Accumulated Expenses peaked at $48895.0 in Q1 2026 and troughed at $6318.0 in Q4 2024.
- A 3-year average of $31042.7 and a median of $37915.0 in 2025 frame the typical range for Accumulated Expenses.
- The widest YoY moves for Accumulated Expenses: up 500.11% in 2025, down 500.11% in 2025.
- Over 3 years, Accumulated Expenses stood at $6318.0 in 2024, then soared by 500.11% to $37915.0 in 2025, then grew by 28.96% to $48895.0 in 2026.
- The last three Accumulated Expenses figures came in at $48895.0 (Q1 2026), $37915.0 (Q4 2025), and $6318.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 9.96 Bn | 9.12 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.47 Bn | 5.47 Bn | - |
| 3 | Iovance Biotherapeutics | 4.64 Bn | 4.35 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.25 Bn | 2.28 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Precigen | 2.79 Bn | 2.79 Bn | 52.17 Mn |
| 7 | Beam Therapeutics | 2.58 Bn | 2.58 Bn | - |
| 8 | Sarepta Therapeutics | 2.12 Bn | 1.33 Bn | 251.87 Mn |
| 9 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn |
| 10 | Adia Nutrition | 11.33 Mn | 11.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 48,895.00 |
| Dec 31, 2025 | 37,915.00 |
| Dec 31, 2024 | 6,318.00 |